CORBION NV (CRBN.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock
18.46 EUR
-0.4 (-2.12%)
We assign a fundamental rating of 5 out of 10 to CRBN. CRBN was compared to 74 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN is valued quite cheap, but it does not seem to be growing. These ratings would make CRBN suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year CRBN was profitable.
CRBN had a positive operating cash flow in the past year.
CRBN had positive earnings in each of the past 5 years.
In the past 5 years CRBN always reported a positive cash flow from operatings.
1.2 Ratios
CRBN's Return On Assets of 4.55% is fine compared to the rest of the industry. CRBN outperforms 68.92% of its industry peers.
With a decent Return On Equity value of 9.12%, CRBN is doing good in the industry, outperforming 67.57% of the companies in the same industry.
CRBN has a better Return On Invested Capital (9.19%) than 75.68% of its industry peers.
CRBN had an Average Return On Invested Capital over the past 3 years of 6.62%. This is in line with the industry average of 6.87%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROIC | 9.19% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
CRBN has a better Profit Margin (5.11%) than 64.86% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
CRBN has a better Operating Margin (8.68%) than 64.86% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
Looking at the Gross Margin, with a value of 26.10%, CRBN is doing worse than 60.81% of the companies in the same industry.
In the last couple of years the Gross Margin of CRBN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
CRBN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CRBN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.76 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CRBN (2.76) is better than 62.16% of its industry peers.
CRBN has a debt to FCF ratio of 4.95. This is a neutral value as CRBN would need 4.95 years to pay back of all of its debts.
The Debt to FCF ratio of CRBN (4.95) is better than 74.32% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
CRBN has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: CRBN outperforms 56.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Altman-Z | 2.76 |
ROIC/WACC1.44
WACC6.37%
2.3 Liquidity
A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
CRBN has a worse Current ratio (1.21) than 79.73% of its industry peers.
CRBN has a Quick Ratio of 1.21. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.60, CRBN is not doing good in the industry: 87.84% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
The Revenue has been growing slightly by 2.95% in the past year.
Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
3.2 Future
CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
The Revenue is expected to decrease by -1.71% on average over the next years.
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y15.24%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y-1.71%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.48 indicates a correct valuation of CRBN.
72.97% of the companies in the same industry are more expensive than CRBN, based on the Price/Earnings ratio.
CRBN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.37, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.33, CRBN is valued correctly.
70.27% of the companies in the same industry are more expensive than CRBN, based on the Price/Forward Earnings ratio.
CRBN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.48 | ||
| Fwd PE | 12.33 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 67.57% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRBN indicates a rather cheap valuation: CRBN is cheaper than 93.24% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.77 | ||
| EV/EBITDA | 7.87 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
CRBN's earnings are expected to grow with 18.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)0.33
EPS Next 2Y21.96%
EPS Next 3Y18.01%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.24%. Purely for dividend investing, there may be better candidates out there.
CRBN's Dividend Yield is a higher than the industry average which is at 3.13.
CRBN's Dividend Yield is a higher than the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.24% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
56.19% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.19%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
AMS:CRBN (12/4/2025, 4:13:25 PM)
18.46
-0.4 (-2.12%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners91.06%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts77.14
Price Target23.33 (26.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.24% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.33%
PT rev (3m)-0.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-1.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.48 | ||
| Fwd PE | 12.33 | ||
| P/S | 0.83 | ||
| P/FCF | 10.77 | ||
| P/OCF | 6.38 | ||
| P/B | 1.48 | ||
| P/tB | 1.7 | ||
| EV/EBITDA | 7.87 |
EPS(TTM)1.12
EY6.07%
EPS(NY)1.5
Fwd EY8.11%
FCF(TTM)1.71
FCFY9.28%
OCF(TTM)2.89
OCFY15.67%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.45
PEG (5Y)0.33
Graham Number17.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROCE | 10.92% | ||
| ROIC | 9.19% | ||
| ROICexc | 9.57% | ||
| ROICexgc | 10.55% | ||
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% | ||
| FCFM | 7.7% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Debt/EBITDA | 1.43 | ||
| Cap/Depr | 81.01% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 7.03 | ||
| Cash Conversion | 85.4% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.76 |
F-Score6
WACC6.37%
ROIC/WACC1.44
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year132.41%
EBIT Next 3Y36.9%
EBIT Next 5Y26.73%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%
CORBION NV / CRBN.AS FAQ
What is the fundamental rating for CRBN stock?
ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.
Can you provide the valuation status for CORBION NV?
ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.
What is the profitability of CRBN stock?
CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CRBN stock?
The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 16.48 and the Price/Book (PB) ratio is 1.48.
Can you provide the dividend sustainability for CRBN stock?
The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.